Viewing Study NCT05338957

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2026-01-31 @ 9:11 PM
Study NCT ID: NCT05338957
Status: UNKNOWN
Last Update Posted: 2022-12-01
First Post: 2022-04-15
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of MRG002 in the Treatment of Patients With HER2-expressed Advanced Malignant Solid Tumors.
Sponsor: Shanghai Miracogen Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Malignant Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MRG002 View
None HX008 View
None Antibody Drug Conjugate (ADC) View
None HER2 View
None PD-1 View
None Solid tumors View